Sunita Nathan MD
Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Associate Professor of Medicine, Rush Medical College of Rush University Associate Director, Section of Bone Marrow Transplant and Cell Therapy Medical Director, Apheresis Program
Join to View Full Profile
1725 W Harrison StSuite 1010Chicago, IL 60612
Phone+1 312-942-5904
Fax+1 312-942-3192
Dr. Nathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sunita Nathan is a hematologist based in Chicago, IL, specializing in hematology with subspecialties in hematologic oncology and myeloproliferative disorder hematology-oncology. She completed her fellowship in hematology and medical oncology and residency in internal medicine at Cook County Health and Hospitals System, after graduating from B.J. Medical College at the University of Pune in 1998. Dr. Nathan has experience with hematopoietic stem cell transplantation and conditions such as acute myeloid leukemia, Hodgkin's lymphoma, multiple myeloma, and lymphoma. She has authored multiple peer-reviewed publications and is involved in clinical trials, including one on blood stem cell transplant for relapsed follicular non-Hodgkin's lymphoma. She has also received the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR.
Education & Training
Cook County Health and Hospitals SystemFellowship, Hematology and Medical Oncology, 2005 - 2008- Cook County Health and Hospitals SystemResidency, Internal Medicine, 2001 - 2004
B.J. Medical College - University of PuneClass of 1998
Certifications & Licensure
IL State Medical License 2004 - 2026
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
Clinical Trials
- Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) Start of enrollment: 2009 Apr 01
Publications & Presentations
PubMed
- 13 citationsCardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk Score.Alexi Vasbinder, Tonimarie Catalan, Elizabeth Anderson, Catherine Chu, Megan Kotzin
Journal of the American Heart Association. 2024-01-02 - 11 citationsIncidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Tr...Genovefa A Papanicolaou, Min Chen, Naya He, Michael J Martens, Soyoung Kim
Transplantation and Cellular Therapy. 2024-01-01 - 14 citationsPost-transplantation cyclophosphamide is associated with increased bacterial infections.Celalettin Ustun, Min Chen, Soyoung Kim, Jeffery J Auletta, Marjorie V Batista
Bone Marrow Transplantation. 2024-01-01
Lectures
- Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
'It Really Sets Us Apart'September 11th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
